Ara
Toplam kayıt 81, listelenen: 11-20
GEMIFLOXACIN-INDUCED ALLERGIC MYOCARDIAL INFARCTION: A CASE REPORT
(Elsevier Science Inc, 2019)
Background: Gemifloxacin given once daily for 5-7 days has been shown to be non-inferior to, or in some instances superior to, comparator agents for the treatment of common lower respiratory tract infections. Gemifloxacin ...
Thrombolysis in pulmonary embolism: full-dose, low-dose, or catheter-directed thrombolysis?
(W B Saunders Co-Elsevier Inc, 2016)
Letter to the Editor
Takotsubo (stress) cardiomyopathy in childhood
(Springer, 2020)
Takotsubo cardiomyopathy (TC) is a significant cause of acute heart failure in adults. However, triggering factors, ECG and echocardiographic findings, and prognosis of TC have not been well studied in children. Therefore, ...
Ivabradine in cardiogenic shock: Fact or fiction?
(Mosby-Elsevier, 2015)
Letter to the Editor
Preoperative Mild Pericardial Effusion Is Associated With Perioperative Complications In Elderly Patients Following Hip Fracture Surgery
(Taylor & Francis Inc, 2020)
Background: The prevalence and prognostic value of mild pericardial effusion (MPE) has not been examined in patients undergoing non-cardiac surgery. Our study aimed to assess the frequency and prognostic value of MPE in ...
Chest tube insertion techniques on YouTube: is social media a reliable source of learning medical skills?
(W B Saunders Co-Elsevier Inc, 2015)
Correspondence
Patients with HFpEF and HFmrEF have different clinical characteristics in Turkey: A multicenter observational study
(Elsevier Science Bv, 2019)
Background: To determine and compare the demographic characteristics, clinical profile and management of patients with heart failure with mid-range ejection fraction (HFmrEF) and heart failure with preserved ejection ...
Metoprolol vs ivabradine in patients with mitral stenosis
(Elsevier Ireland Ltd, 2016)
[No abstract available]
Risk stratification in intermediate-risk acute pulmonary embolism
(W B Saunders Co-Elsevier Inc, 2016)
Non-invasive ventilation in community acquired pneumonia
(W B Saunders Co-Elsevier Inc, 2019)